Stockreport

RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement

RenovoRx, Inc.  (RNXT) 
PDF LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precisio [Read more]